Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Liver Diseases

Free Subscription Articles published in Dig Dis Retrieve available abstracts of 28 articles: HTML format

Single Articles

August 2025
1. LI W, Tian Y, Jing L
   Diagnostic value and prognostic effect of miR-7-5p in cirrhosis.
   Dig Dis. 2025 Aug 13:1-17. doi: 10.1159/000547157.
   PubMed     Abstract available
   
   
   June 2025
2. XU Y, Zhang X, Wang H, Liu Z, et al
   Long-term outcome of repeat resection versus radiofrequency ablation for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within BCLC 0-A stages: A multicenter study.
   Dig Dis. 2025 Jun 24:1-20. doi: 10.1159/000546743.
   PubMed     Abstract available
   
   
   May 2025
3. LIU JK, Chien N, Chong C, Barnett S, et al
   Projected Tumor Characteristics and Survival of Patients with Nonviral Hepatocellular Carcinoma in the United States.
   Dig Dis. 2025 May 28:1-20. doi: 10.1159/000546600.
   PubMed     Abstract available
   
   
   February 2025
4. HUANG YJ, Lee SW, Tung CF, Liao SC, et al
   HBV relapse after discontinuation of Tenofovir alafenamide or Entecavir in non-cirrhotic HBeAg-negative patients.
   Dig Dis. 2025 Feb 21:1-15. doi: 10.1159/000544870.
   PubMed     Abstract available
   
   
   
5. ZHOU Z, Ge S, Gu C, Chen J, et al
   Improving Outcomes in Hepatocellular Carcinoma through Integration of Machine Learning: Development of a Tumor-Associated Macrophage Signature.
   Dig Dis. 2025 Feb 1:1-19. doi: 10.1159/000543642.
   PubMed     Abstract available
   
   
   January 2025
6. DAZA J, Espinosa-Montagut N, Kautz A, Langenbacher D, et al
   Symptom Reporting in Patients with Primary Biliary Cholangitis: Higher Burden of Symptoms detection using an interactive App.
   Dig Dis. 2025 Jan 14:1-18. doi: 10.1159/000543229.
   PubMed     Abstract available
   
   
   
7. ZHENG H, Guo T, Zhao X, Wang K, et al
   Helicobacter pylori Infection Is Not Associated with Nonalcoholic Fatty Liver Disease: A Two-Year Cohort Study.
   Dig Dis. 2025;43:75-83.
   PubMed     Abstract available
   
   
   
8. ZHANG J, Hu J, Li Y, Zhou X, et al
   Serum Autotaxin Level Positively Associates with Metabolic-Associated Fatty Liver Disease and Hyperuricemia in Postmenopausal Women.
   Dig Dis. 2025;43:54-62.
   PubMed     Abstract available
   
   
   
9. ZHANG X, Kam LY, Barnett SD, Henry L, et al
   Disease Progression for Histologic Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Real-World: A Nationwide US Study.
   Dig Dis. 2025;43:36-45.
   PubMed     Abstract available
   
   
   
10. GARCIA EM, Nerurkar SN, Tan EX, Tan SYS, et al
    Characteristics and Outcomes of Elderly Hepatocellular Carcinoma Patients following Surgical Resection: Systematic Review and Meta-Analysis.
    Dig Dis. 2025;43:206-214.
    PubMed     Abstract available
    
    
    September 2024
11. IWASAKI S, Uojima H, Sakita S, Masuda S, et al
    Esophageal varices as an independent predictor of fatal outcomes after balloon-occluded retrograde transvenous obliteration in patients with hepatic encephalopathy.
    Dig Dis. 2024 Sep 30:1-15. doi: 10.1159/000541660.
    PubMed     Abstract available
    
    
    June 2024
12. NEYE RM, Kircheis G, Stratmann D, Hilger N, et al
    Assessment of Cirrhotic Patients by the EncephalApp Fails to Predict Low-Grade Hepatic Encephalopathy.
    Dig Dis. 2024 Jun 12. doi: 10.1159/000538924.
    PubMed     Abstract available
    
    
    April 2024
13. TAKI S, Ida Y, Tamai H, Maeshima S, et al
    Lusutrombopag Reduces the Risk of Hemoperitoneum Caused by Percutaneous Radiofrequency Ablation for Hepatocellular Carcinoma Compared with Platelet Transfusion.
    Dig Dis. 2024 Apr 25. doi: 10.1159/000539006.
    PubMed     Abstract available
    
    
    
14. MORKUNAS E, Vaitkeviciute E, Inciuraite R, Kupcinskas J, et al
    miRNome profiling analysis reveals novel hepatocellular carcinoma diagnostic, prognostic and treatment-related candidate biomarkers: post-hoc analysis of SORAMIC trial.
    Dig Dis. 2024 Apr 24. doi: 10.1159/000538757.
    PubMed     Abstract available
    
    
    
15. TEUFEL A, Kudo M, Qian Y, Daza J, et al
    Current Trends and Advancements in the Management of Hepatocellular Carcinoma.
    Dig Dis. 2024 Apr 10. doi: 10.1159/000538815.
    PubMed     Abstract available
    
    
    March 2024
16. LEMMER P, Rohr LC, Henning M, Bulut K, et al
    Liver stiffness determined by transient elastography is a simple and highly accurate predictor for presence of liver cirrhosis in clinical routine.
    Dig Dis. 2024 Mar 25. doi: 10.1159/000538426.
    PubMed     Abstract available
    
    
    January 2024
17. WU PS, Hsieh YC, Lee PC, Yang TC, et al
    Mac-2 Binding Protein Glycosylation Isomer to Albumin Ratio Predicts Bacterial Infections in Cirrhotic Patients.
    Dig Dis. 2024 Jan 12. doi: 10.1159/000535325.
    PubMed     Abstract available
    
    
    
18. MANSOUR N, Sirtl S, Angele MK, Wildgruber M, et al
    Management of Sinistral Portal Hypertension After Pancreaticoduodenectomy.
    Dig Dis. 2024 Jan 5. doi: 10.1159/000535774.
    PubMed     Abstract available
    
    
    
19. UOJIMA H, Sakaguchi Y, Gotoh K, Satoh T, et al
    Metabolic Dysfunction-Associated Fatty Liver Disease on Distinct Microbial Communities at the Bacterial Phylum Level.
    Dig Dis. 2024;42:61-69.
    PubMed     Abstract available
    
    
    
20. LI H, Yu S, Chen L, Liu H, et al
    Immunomodulatory Role of Mesenchymal Stem Cells in Liver Transplantation: Status and Prospects.
    Dig Dis. 2024;42:41-52.
    PubMed     Abstract available
    
    
    
21. NGUYEN BT, Nguyen VH, Le M, Henry L, et al
    Impact of Income-to-Poverty Ratio on Long-Term Mortality of Persons with Chronic Liver Disease in the USA, 1999-2018.
    Dig Dis. 2024;42:473-485.
    PubMed     Abstract available
    
    
    
22. UMUTLU MR, Ocal O, Puhr-Westerheide D, Fabritius MP, et al
    Efficacy and Safety of Local Liver Radioablation in Hepatocellular Carcinoma Lesions within and beyond Limits of Thermal Ablation.
    Dig Dis. 2024;42:461-472.
    PubMed     Abstract available
    
    
    
23. CHEN CC, Huang YK, Wang RC, Fu JT, et al
    Validating the Baveno Elastography Criteria of Advanced Liver Fibrosis in Two-Dimensional Shear Wave Elastography: A Prospective Pathology-Based Study.
    Dig Dis. 2024;42:452-460.
    PubMed     Abstract available
    
    
    September 2023
24. TAN D, Chan KE, Wong ZY, Ng CH, et al
    Global Epidemiology of Cirrhosis: Changing Etiological Basis and Comparable Burden of NASH between Males and Females.
    Dig Dis. 2023 Sep 13. doi: 10.1159/000533946.
    PubMed     Abstract available
    
    
    January 2023
25. ITZEL T, Falconer T, Roig A, Daza J, et al
    Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.
    Dig Dis. 2023;41:780-788.
    PubMed     Abstract available
    
    
    
26. LE MH, Henry L, Cheung R, Nguyen MH, et al
    Transient Elastography and Serum-Based Tests for Diagnosis of Fatty Liver and Advanced Fibrosis in a Community Cohort: A Cross-Sectional Analysis.
    Dig Dis. 2023;41:767-779.
    PubMed     Abstract available
    
    
    
27. ANDROUTSAKOS T, Dimitriadis K, Revenas K, Vergadis C, et al
    Liver Biopsy: To Do or Not to Do - A Single-Center Study.
    Dig Dis. 2023;41:913-921.
    PubMed     Abstract available
    
    
    
28. FU Z, Cheng P, Jian Q, Wang H, et al
    High Systemic Immune-Inflammation Index, Predicting Early Allograft Dysfunction, Indicates High 90-Day Mortality for Acute-On-Chronic Liver Failure after Liver Transplantation.
    Dig Dis. 2023;41:938-945.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.